Robotic pets and staff-led sessions leased to dementia day-care and care homes
TL;DR Mellowpaw leases robotic companion pets to dementia day-care centres and assisted-living homes, along with a session plan, staff training and a cleaning routine. The care operator pays a monthly fee per site. It could work because staff need calm, structured activities, and the evidence points to engagement rather than cure.
About 7.2% of Indians over 60 live with dementia, roughly 9.9 million people[1]. Most are cared for at home, but a growing number spend days or months in day-care centres and care homes.
Those places struggle to fill long afternoons. Residents get restless, staff spend their time calming one person after another, and families judge a home by whether their parent seemed settled. Live animals are rarely allowed, for hygiene and safety reasons. I found no public count of dementia care homes or day-care centres in India, which tells you how young this sector is.
What it does, in regulatory terms: an activity and engagement aid only. Mellowpaw does not claim to treat, reduce or manage dementia symptoms, so it should sit outside the Medical Devices Rules 2017. Any claim of reduced agitation or depression would change that, so confirm the position with a regulatory adviser.
The seed pitched socially assistive robots that tackle isolation and health decline, and I've reframed it. Humanoid assistants are costly and the evidence for health effects is thin - a 2025 meta-analysis found robotic pets had a non-significant effect on depression in older adults[2]. What staff do report is engagement and calmer moments[3]. So Mellowpaw sells exactly that, honestly.
Each site gets a set of robotic cats or dogs that purr, move and respond to touch. It also gets a printed session plan for small groups and one-to-one use, a cleaning protocol between residents and a named staff champion trained by Mellowpaw. A monthly visit checks the pets, swaps faulty units and reviews which residents respond.
The operator of an assisted-living home, a dementia day-care centre or a senior-care chain pays. Families already pay eldercare companies ₹1,999–10,999 a month for memberships[4], so operators are already used to charging for add-ons. My assumption is ₹6,000–12,000 a month per site for a set of pets, sessions and support.
India's eldercare companies are adding paid services and senior-living projects, and families compare homes on the activities they offer. The research on robotic pets has grown up too. A 2025 scoping review of 42 studies spells out what makes them work in care settings - training, one staff champion and a clear cleaning routine[3]. That's a service someone can sell.
Nobody publishes a figure for spending on activity programmes in Indian dementia care. The firm number is the population, about 9.9 million older adults living with dementia[1]. How many attend day-care or live in care homes isn't published, so count the operators in your first city before you size the business.
Abroad, a Japanese robotic seal has been studied for years in homes and care facilities[5], and cheaper robotic cats and dogs are sold to families. In India, eldercare companies offer companionship visits and activity programmes, but I found none leasing robotic pets with training. So the gap is the service layer - choosing residents, running sessions and keeping shared pets clean.
| Difficulty | Moderate (34/100) |
| Starting capital | ₹26–51 L |
| Time to launch | 4–6 months |
You buy the pets in, so the hard parts are human. Staff have to believe the pets aren't childish, families have to agree to their use, and someone has to decide how to answer a resident who thinks the cat is real. Selling takes time too, because many operators are small and watch every rupee.
No licence is needed if you stick to engagement and activity claims. The moment you claim a health benefit, the picture changes.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't use AI to judge a resident's mood, health or cognitive state. Mellowpaw is an activity aid, not a clinical tool.
Want to work out the AI layer for Mellowpaw? Talk to Yash →
It's a small, low-capital idea and I think it fits a founder with an occupational therapy or eldercare operations background. It is not a technology business, so if you're hoping to build a robot then look elsewhere. Prove one thing first - at least half the residents offered a pet still engage with it after eight weeks.
Plan for roughly ₹26–51 L, mostly on the pets themselves, staff training and the time it takes to sign small operators.
Not if you claim only engagement and activity. Health claims could make it a medical device under CDSCO rules, so get regulatory advice, and cover WPC, BIS and DPDP too.
Yes, care homes in many countries already use robotic pets. Check how the local regulator treats health claims and the consent rules for residents.
The free Mellowpaw validation kit has the line-by-line capital breakdown, the effort scoring, the medical-device and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for care operators, and 5 assumptions to test. Download the kit →
Thinking about building Mellowpaw or something close to it? The make-or-break work is getting care staff to use the pets well, week after week. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.